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Abstract. Clinical and biological evaluations were carried out on 84 Congolese patients 
with parasitologically confirmed Loa loa filariasis (without concurrent infection with other 
filariae) and on 98 controls without filariasis. Of the patients, 72 presented with microfil- 
aremia; another 12 with negative blood tests were seen towards the end of an episode of 
subconjunctival migration of the adult worm. The incidence and severity of the clinical 
signs depended upon the method of recruitment. The 3 most common signs were pruritus 
and edema (both occurring in successive acute episodes affecting mainly the hands and 
forearms) and subconjunctival migration of adult filariae. Papulovesicular eruptions were 
located mainly on the arms. Headaches and arthralgia were noted more frequently than in 
the controls. No relation was found between the ABO blood groups and loiasis. Eosinophilia 
(higher in patients with symptoms) and raised serum IgE levels were found in nearly all 
patients and were strongly marked in -66%. A positive correlation was observed between 
these 2 parameters. Fluorescent antibody levels (adult filaria Dipetalonema viteae antigen) 
were comparatively low in patients with microfilaremia. 
Loa loa filariasis occurs exclusively in Africa 
and is endemic in the rain forest of Central Af- 
rica. In the Congo, loiasis is found chiefly in the 
southern and central areas of the country in 
cleared or primary forest areas.' In some villages, 
the prevalence of microfilarial carriers was about 
40O/0,~ a very high rate which has seldom been 
exceeded.' 
Although the clinical signs of loiasis are well- 
known, subconjunctival migration of the adult 
worm having been reported for the first time by 
Mongin in 1770; most publications present iso- 
lated cases usually observed in European or 
American expatriates. Moreover, many publi- 
cations on the symptomatology of this filariasis 
deal with proven or suspected visceral, mostly 
cerebral but also cardiac or renal, complications. 
This aspect was emphasized recently by Nutt- 
man and others5 in their report of 20 cases oc- 
curring in temporary residents. Indeed, none of 
the 73 references mentioned the usual manifes- 
tations of loiasis observed in large numbers of 
indigenous patients. The same applies to our 
complementary survey of the literature. Thus we 
thought it would be interesting to report a clinical 
and biological study of 84 Congolese patients 
with loiasis without concurrent infection with 
other filariae. 
MATERIAIS AND METHODS 
Between 1984 and 1986, 142 patients with 
parasitologically confirmed microfilaremia fila- 
riasis and 98 control subjects without filariasis, 
all Congolese, were enrolled in a systematic study 
conducted at the Institut Supérieur des Sciences 
de la Santé in Brazzaville. Two-thirds of the pa- 
tients had been referred by the Blood Bank of 
the Brazzaville General Hospital after microfi- 
lariae had been detected in their blood. The oth- 
ers had been referred by various health centers 
of the city for examination by a specialist. The 
control subjects also came from the Blood Bank, 
but did not present with microfilaremia, dermal 
microfilariae, or previous histories ofadult worm 
migration. The control subjects and filariasis pa- 
tients sent by the Blood Bank were either vol- 
untary blood donors or, more often, relatives or 
friends of hospitalized patients receiving blood 
transfusions. 
In order to detect filarial infection, each patient 
was interviewed about their medical history, cur- 
rent signs, and specific medication. A routine 
clinical examination was camed out to detect 
pruritus, skin eruptions, edema, arthralgia, head- 
aches, subcutaneous cysts, and subcutaneous and 
subconjunctival migration of adult worms. 
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TABLE 1
Predominant clinical signs observed in 84 loiasis patients (without concurrent infection with otherfilariae) and in 
98 control subjects 
Control subjects Group I patients. Group II patients? 
n = 54 n = 30 n = 98 
Infrequent, Infrequent, Infrequent, 
former, former, former, 
nonexistent, or nonexistent, or nonexistent, or 
Freauent unintcmretable Frenuent unintemretable Freauent uninremretable 
pruritus+ 27 (50%) 27 (50%) 25 (83.8%) 5 (16.7vo) 8 (8.2%) 90 (91.8%) 
Skin eruptions 15 (27.8Vo) 39 (72.2%) 10 (33.3%) 20 (66.7%) 5 (5.1Yo) 93 (94.9%) 
Edemas 1 1  (20.4%) 43 (79.6%) 25 (83.3Yo) 5 (16.7%) 2 (2%) 96 (98%) 
Arthralgia 8 (14.8%) 46 (85.2%) 8 (26.7%) 22 (73.3vo) 7 (7.1vo) 91 (92.9yo) 
Headache 16 (29.6%) 38 (70.4%) 10 (33.3%) 20 (66.7%) 12 (12.2%) 86 (87.8%) 
Group I Group II 
Nonexistent or Nonexistent or 
AFB Migration Recent Former uninterpretable Recent Former uninterpretable 
Subconjunctival 5 (9.3) 16 (29.6) 33 (61.1) 19 (63.3) 4 (13.3) 7 (123.3) 
Cutaneous O l ( l .9 )  53 (98.1) 2 (6.7) l(3.3) 7 (90) 
* Patients referred by the Blood Bank of Braeaville General Hospital. 
t Patients referred to the parasitology outpatient department by health centers. 
*Excluding pruritus after chloroquine. 
5 AF = Adult Filariae. 
Laboratory tests included the detection and 
enumeration of microfilariae in the blood and 
skin. Two thick smears of capillary blood, cali- 
brated at 20 mm3, were taken from patients' fin- 
gertips between O900 and 1100 hours. The mean 
microfilarial density was evaluated each time (re- 
sult given for 20 mm3). Two calibrated (2.3 mm 
Holth pliers) snips taken from the iliac crests 
were placed in 50 pl saline and read after 2-4 hr. 
Overall, 142 patients presented With microfil- 
aremia filariasis. Of these, 84 showed loiasis 
without concurrent infection with other filariae 
by parasitological blood and skin tests. Among 
these, 7 2  showed microfilaremia after exami- 
nation of 40 mm3 blood; 12 patients With neg- 
ative blood tests were seen towards the end of 
episodes of subconjunctival migration of adult 
worms, confirmed by physicians. The Blood Bank 
referred 54 cases (Group I) and health centers 
referred 3 0  cases (Group II). The 98 control sub- 
jects were all referred by the Blood Bank. As a 
result of the recruitment method, a large pro- 
portion of both loiasis patients and control sub- 
jects were men aged 20-40 years. The patients 
were comprised of 6 1 men (72.6%) and 2 3  wom- 
en (age 10-70 years; mean 34 years). The controls 
were comprised of 74 men (75.5%) and 24 wom- 
en (age 18-52 years; mean 31 years). 
The majority of loiasis patients and a fair pro- 
portion of the controls underwent the following 
additional laboratory tests: ABO blood grouping 
(53 patients and 80 controls); evaluation of eo- 
sinophilia (57 patients and 37 controls); deter- 
mination of total IgE levels using an immu- 
noenzyme technique (Phadezym IgE Prist Kits, 
Pharmacia, France) for 5 1 patients and 40 con- 
trols; and screening for antibodies to filariasis by 
indirect immunofluorescence (IIF) using 5 pm 
thick frozen sections of adult filaria Dipetalo- 
nema viteae embedded in a hamster heart as an- 
tigen (58 patients and 78 controls). 
RESULTS 
CIinical manifestations 
The incidence and characteristics of the main 
clinical manifestations of loiasis observed are 
summarized in Tables 1 and 2. Pruritus, skin 
eruptions, edema, arthralgia, and headaches were 
classified into 2 categories: as manifestations oc- 
curring frequently or as former manifestations, 
unstated, or uninterpretable responses. Head- 
aches were considered frequent if they occurred 
at least twice a month other than during fever. 
Observations regarding adult worm migration 
were classified into 3 categories: recent episodes 
(occurring within the previous 3 months), former 
episodes, and unstated or uninterpretable re- 
sponses. In control subjects, this symptom was 
of course nonexistent, since only individuals who 
denied its occurrence were selected as controls. 
Patients in Group II showed more symptoms 
(both edema and pruritus occurred in 83.8% of 
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the cases) than patients in Group I (20.4% pre- 
sented edema, 50% pruritus). This difference can 
be accounted for by the method of recruitment. 
In the control subjects, edema and pruritus were 
observed in only 2% and 8.2% of the cases, re- 
spectively. Since adult worm migration (subcon- 
junctival rather than cutaneous) is a frequent rea- 
son for seeking medical advice, it is not surprising 
that this symptom occurred more frequently in 
Group II (78.6%). However, adult worm migra- 
tion was reported in nearly 33% of patients in 
Group I. Furthermore, 12 ofthe 19 patients (63O/o) 
in Group II with recent subconjunctival migra- 
tion had no detectable microfilaremia. For head- 
ache and arthralgia, which are not typically fi- 
larial manifestations, significant differences were 
observed between Group II patients (33% and 
27%, respectiveiy) and control subjects (12% and 
7%, respectively; P < 0.01). The incidence of 
headache was also higher in Group I patients 
than in the controls (30% vs. 12%; P < 0.05). 
The common characteristics of the predomi- 
nant signs, pruritus and edema, were determined 
by considering only the patients (in both groups) 
who had given sufficiently precise replies at the 
interview (Table 2). Pruritus was taken into ac- 
count only if it was unrelated to 4-aminoquin- 
oline therapy and if real discomfort was expe- 
rienced. Edema was considered frequent if it 
occurred at least every 2 months, and transient 
if it lasted <3  days. Pruritus was found to be 
localized in most cases, mainly on the hands, 
wrists, and forearms. It was characterized by suc- 
cessive acute episodes and various degrees of se- 
verity. Similarly, edema affected preferentially 
the hands, wrists, and forearms. Edema on the 
face, the classic localization, was rare. Although 
painless and transient in most patients, it some- 
times caused marked functional impairment and 
the migratory aspect was not always obvious. 
The arms were also the preferential site for skin 
eruptions. Headaches were characterized mostly 
as hammering in the forehead. Arthralgia often 
affected several joints, primarily the knees and 
wrists; the elbows and ankles were also frequent- 
ly mentioned, but not the shoulders, hips, or 
hands. 
Biological data 
Microfilarial density. In the 72 patients with 
microfilaremia, the mean microfilarial density 
was 58.7/20 mm3 (range 0.5-340). There were 
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TABLE 3
Distribution offiariasis patients and control subjects by blood type 
Blood types 
A B AB O 
Loiasis patients 
n=53 17% 15.1% 7.5% 60.4% 
Control subjects I* 
Control subjects II? 
n = 80 22.5% 20% 5% 52.5% 
n = 13,045 21.7% 21.1% 3.7% 53.4% 
*Subjects with negative tests for filariasis. 
t Total of blood donon in 1985. 
no differences between Group I and Group II 
patients. 
ABO bloodgroup. The ABO blood distribution 
was similar among loiasis patients and control 
subjects. Type O was found in slightly more than 
50% of the subjects, types A and B in about 20% 
each, and type AB was infrequent (Table 3). 
Eosinophilia. Eosinophilia was found in nearly 
all cases (>500/mm3 in 94.7% of the patients). 
The level was high (> l,000/mm3) in 68.4%, with 
a mean of 1,457/mm3 and a range of 248-3,341). 
Of the control subjects, 27% presented eosino- 
philia levels of >500/mm3 and 5.4% levels 
> l,000/mm3; the mean level for controls was 
279/mm3 and the range was 210-1,324. The level 
was higher in Group II patients than in Group I 
patients (1,807/mm3 vs. 1,322/mm3; t = 2.29, 
df = 55, P < 0.05). In the 4 patients without 
detectable microfilaremia but with measured eo- 
sinophilia, the level was 2,295/mm3 (Table 4). 
Serum &E. IgE levels were high. Over 600 
IU/ml were found in 80.4% of the cases, and 
>2,000 IU/ml in 66%. The mean level of 4,280 
IU/ml is lower than the true mean, as values 
> 15,000 IU/ml, observed in 4 cases, were not 
exact determinations. The mean IgE levels were 
similar in Groups I and II. In the control subjects, 
IgE values were also high, though much lower 
than in the patients. The mean level for controls 
was 1,680 IU/ml with a range of 5O-7,200. Levels 
> 600 IU/ml and > 2,000 IU/ml were present in 
72.5% and 25.5% of the subjects, respectively 
(Table 4). 
Speczfifluorescent antibodies. A titer of at least 
1/200, considered as indicative of immunolog- 
ical filariasis with the method used in this study, 
was found in only 51.7% of the cases. The geo- 
metrical mean reciprocal titer (GMRT) was 69.3 
(range 63,200). It should be noted that of the 5 
patients without microfilaremia who had expe- 
rienced a recent episode of filarial migration, 4 
presented positive serologic results. Among the 
controls, 12.8% were positive and the GMRT 
was 9.8 With the highest level being 800 (Table 
4). 
Correlations. A positive correlation was noted 
for IgE and eosinophilia levels in loiasis patients 
(47 validated, r = 0.341, P = 0.019). This cor- 
relation can be taken into account since the dis- 
tribution for eosinophilia was normal, but de- 
viated slightly for IgE levels. Two other positive 
correlations related to loiasis patients were ob- 
served IgE level-IIF titer and microfilaremia- 
IIF titer. These correlations are questionable, 
since the distribution of IIF titer deviated too far 
from the normal distribution. 
DISCUSSION 
In endemic areas, Loa loa filariasis often oc- 
curs with Mansonella perstans filariasis and 
sometimes with onchocerciasis or even with 
streptocerciasis. These 4 diseases are endemic in 
the Congo,’, unlike lymphatic filariasis, which 
we have never diagnosed in indigenous subjects. 
Among 142 patients with microfilaremia fila- 
riasis in our study, 20 presented with L. loa and 
M. perstans, 9 with L. loa and Onchocerca vol- 
vulus, l with L. loa, M. perstans, and O. volvulus, 
and 28 with M. perstans alone. 
In the absence of published investigations on 
loiasis involving sufficiently large numbers of pa- 
tients with parasitological evidence in which oth- 
er filarial infections are excluded, it is difficult to 
make any comparative analysis of the usual clin- 
ical and biological signs of the disease. Although 
fewer symptoms are observed in the indigenous 
population than in temporary residents, in spite 
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TABLE 4
Blood eosinophilia, total serum IgE, and fluorescent filaria antibody levels 
Percent 
M W *  positive 
(threshold 
n Ar Geo Rangt 11200) 
Blood E~sinophilidmm~ Patients 
Group I 41 1,322 - 248-3,105 - 
Group II 16 1,807 - 536-3,341 - 
Total 57 1,457 - 248-3,341 - 
Control 37 279 - 2161,324 - 
IU/mlt Group I 39 4,324 - IO&> 15,000 - 
Group II 12 4,131 - 126>  15,000 - 
Total 51 4,280 - lo&> 15,000 - 
Serum IgE Patients 
Control 40 1,680 - 567,200 - 
Filarial IIF Patients 
Reciprocal titer$ Group I 42 - 66.4 63,200 5 0% 
Group II 16 - 77.4 61,600 56.2% 
Total 58 - 69.3 O-3,200 5 1.7% 
Control 78 - 9.3 e800 12.8% 
*Ar = Arithmetic; Geo = Geometrical. t Levels above 15.000 IU/ml(4 patients) were not exactly determined, thus the true means are greater than those shown. 
f Rather than a geometrical mean &prod titer, this is a William's mean taking hm amunt the values equal to zero. The value of zero was 
attributed to the cases for whom the reaction was negative at a dilution of 1/100. 
of the fact that microfilaremia develops less fre- 
quently in temporary residents5 (this also applies 
to lymphatic filariasis),', we have demonstrated 
in this study that such symptoms do occur. The 
incidence and severity of clinical signs depend 
on the method of recruitment, being higher in 
the patients referred by the health centers. How- 
ever, symptom-free forms are not infrequent. A 
good host-parasite adaptation is the argument 
commonly put forward to explain this fact.g This 
may involve a genetic predisposition,'O immu- 
nological receptiveness following prenatal sen- 
sitization,lI or both. Tissue and blood groups do 
not seem to be involved. 
In contrast with other forms of microfilaremia 
filariasis, the number of carriers of Loa loa mi- 
crofilariae does not usually exceed 33% of the 
population,3 even in hyperendemic areas. It is 
interesting to note the large numbers of cases of 
conjunctival adult filaria migration in subjects 
without detectable microfilaremia, in spite of the 
high fertility of the female wom.l3 This was ob- 
served as early as 19 1 314 and again in this study 
(12 cases). 
Pathological manifestations are mainly related 
to allergic reactions produced by the elimination 
of antigenic substances by migrating adult filariae 
or by microfilariae recently released in the der- 
mis. 15 .16  The same antigens produce eosinophilia 
and high IgE levels, which in turn produce a 
defense mechanism with antibody-dependent cell 
cytot~xicity,~~ which is partly responsible for the 
destruction of microfilariae. 
The arms are the preferential site of pruritus, 
edema, and skin eruption. Localization on the 
hands and the lower half of the forearms, espe- 
cially for edema, seems highly suggestive of loia- 
sis. It is rarely found in onchocerciasis. The char- 
acteristics of edema (occurring in successive acute 
episodes, moving from 1 place to another) are 
also quite different from edema occurring in oth- 
er filariasis. Although painless, they often cause 
functional impairment and numbness. This pref- 
erential localization seems to be related to the 
site of adult fìlariae. In 1905, Penells reported 
the dissection of a patient which revealed 34 adult 
worms in the superficial connective tissue and 
under the superficial aponeurosis of limb mus- 
cles and tendons, primarily in the arms. 
Filariae creeping beneath the skin is seldom 
demonstrated in Africans, but the worm can be 
found in edema, leading to abscess formation 
following specific therapy. This was seen on 2 
recent occasions in the Congo (data not shown). 
Migration under the conjunctiva is frequent and, 
as a rule, quite benign. Following treatment with 
local remedies and for unsuccessful attempts at 
extraction, the filariae may die in situ and remain 
I 
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there for several months without any marked 
functional impairment. l9 Intra-ocular involve- 
ment is extremely rare, and is probably due to 
the early penetration of a larva via the blood and 
not to the penetration of an adult worm through 
the sclera.20 
The incidences of headache and arthralgia, 
which are not the usual signs of loiasis, are worth 
noting. These symptoms occurred or became 
more severe in the first few days of treatment 
with Diethylcarbamazine (DEC), this being re- 
lated to microfilaria lysis.21 Microfilariae have 
been demonstrated in synovial fluid.22 No clin- 
ically-obvious glandular lesions were observed.23 
The classical visceral complications (en- 
cephalitic, cardiac, and renal) were not system- 
atically or satisfactorily investigated. Few pa- 
tients in our study had a high density of 
microfilariae. The mean microfilarial density was 
comparatively low, the maximum density being 
340/mm3. Given the periodicity of microfilare- 
mia, blood samples were always taken after O900 
hours, when microfilaremia was at at least 50% 
of its maximum value (maximum reached at 1300 
hours).*4 Most of the patients had resided several 
years in Brazzaville where loiasis is not trans- 
mitted. Transmission occurs in surrounding ru- 
ral areas. The southwest of the Congo is a highly 
endemic region. Recently, 6 cases of loiasis en- 
cephalitis following DEC therapy were ob- 
served?’ 
A relationship between the ABO blood groups 
and Wuchereria bancrofti filariasis, showing a 
’ larger number of type A subjects and .a lesser 
number of type B subjects, has been reported in 
Japan.26 No such relationship could be found for 
loiasis in Nigeria?’ 
Similarly, few publications refer to therise in 
blood eosinophilia or IgE level. Each case was 
reported individually and always occurred in 
temporary  resident^.^ Until this study, our ex- 
perience in the Congo was similar. The findings 
presented here show that eosinophilia and raised 
IgE levels also occur in the indigenous popula- 
tion, but the values are lower. Persistent high 
eosinophilia may be the cause of chronic African 
endomyocardial fibrosis.28 It is interesthg to note 
the positive correlation between eosinophilia and 
IgE levels and also the higher levels of eosino- 
philia in Group II patients who exhibited more 
symptoms. 
The low sensitivity of IIF serological tests can 
partly be accounted for by the high percentage 
of patients with microfilaremia (54 of 58 tested). 
Indeed, microfilaremic patients With filariasis in 
genera129 and loiasis in particular30 have lower 
antibody levels than patients without microfil- 
aremia. The results obtained in the controls (pos- 
itive in 13% of the cases) suggest that some of 
the subjects may have had filanasis Without spe- 
cific clinical or parasitological manifestations. 
However, false positive responses related to 
another helminthiasis, in spite of the high thresh- 
old selected, cannot be ruled out. The compar- 
atively high eosinophilia and serum IgE levels 
are also indicative of concurrent parasitic 
infection31 (for example, intestinal nematode in- 
fections, which are quite frequent in Brazzaville 
itselfJ2 and in unscreened filariasis patients). 
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